291 related articles for article (PubMed ID: 36325523)
1. The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease.
Krashia P; Spoleti E; D'Amelio M
Front Psychiatry; 2022; 13():1039725. PubMed ID: 36325523
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
3. Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
Serra L; D'Amelio M; Esposito S; Di Domenico C; Koch G; Marra C; Mercuri NB; Caltagirone C; Artusi CA; Lopiano L; Cercignani M; Bozzali M
J Alzheimers Dis; 2021; 82(3):985-1000. PubMed ID: 34120905
[TBL] [Abstract][Full Text] [Related]
4. Volume and Connectivity of the Ventral Tegmental Area are Linked to Neurocognitive Signatures of Alzheimer's Disease in Humans.
De Marco M; Venneri A
J Alzheimers Dis; 2018; 63(1):167-180. PubMed ID: 29578486
[TBL] [Abstract][Full Text] [Related]
5. Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease.
La Barbera L; Vedele F; Nobili A; Krashia P; Spoleti E; Latagliata EC; Cutuli D; Cauzzi E; Marino R; Viscomi MT; Petrosini L; Puglisi-Allegra S; Melone M; Keller F; Mercuri NB; Conti F; D'Amelio M
Prog Neurobiol; 2021 Jul; 202():102031. PubMed ID: 33684513
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
7. Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.
Spoleti E; Krashia P; La Barbera L; Nobili A; Lupascu CA; Giacalone E; Keller F; Migliore M; Renzi M; D'Amelio M
Exp Neurol; 2022 Apr; 350():113969. PubMed ID: 34973962
[TBL] [Abstract][Full Text] [Related]
8. Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease.
Cordella A; Krashia P; Nobili A; Pignataro A; La Barbera L; Viscomi MT; Valzania A; Keller F; Ammassari-Teule M; Mercuri NB; Berretta N; D'Amelio M
Neurobiol Dis; 2018 Aug; 116():142-154. PubMed ID: 29778899
[TBL] [Abstract][Full Text] [Related]
9. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
10. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
Iaccarino L; Sala A; Caminiti SP; Presotto L; Perani D;
J Alzheimers Dis; 2020; 75(3):1003-1016. PubMed ID: 32390614
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
12. Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans.
D'Amelio M; Serra L; Bozzali M
J Alzheimers Dis; 2018; 63(1):181-183. PubMed ID: 29630556
[TBL] [Abstract][Full Text] [Related]
13. Functional network topology associated with apathy in Alzheimer's disease.
Tumati S; Marsman JC; De Deyn PP; Martens S; Aleman A;
J Affect Disord; 2020 Apr; 266():473-481. PubMed ID: 32056915
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
[TBL] [Abstract][Full Text] [Related]
15. Ethanol directly excites dopaminergic ventral tegmental area reward neurons.
Brodie MS; Pesold C; Appel SB
Alcohol Clin Exp Res; 1999 Nov; 23(11):1848-52. PubMed ID: 10591603
[TBL] [Abstract][Full Text] [Related]
16. The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice.
D'Amelio M; Puglisi-Allegra S; Mercuri N
Pharmacol Res; 2018 Apr; 130():414-419. PubMed ID: 29391234
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Neuropsychiatric Symptoms across the Declining Memory Continuum: An Observational Study in a Memory Clinic Setting.
Zhang M; Wang H; Li T; Yu X
Dement Geriatr Cogn Dis Extra; 2012 Jan; 2(1):200-8. PubMed ID: 22719746
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
